Evobiotics is developing novel antimicrobial compounds to treat bacterial & fungal infections

Evobiotics is developing novel antimicrobial compounds to treat bacterial & fungal infections
<span>Evobiotics was founded In 2016 with the purpose of discovering novel antimicrobial compounds to treat bacterial &amp; fungal infections in humans. It is currently supported by seed funding from Acidophil, and is seeking grants in 2019 to fund its research and development efforts.</span>

Evobiotics was founded In 2016 with the purpose of discovering novel antimicrobial compounds to treat bacterial & fungal infections in humans. It is currently supported by seed funding from Acidophil, and is seeking grants in 2019 to fund its research and development efforts.

Source: acidophil.com